LHC Group (LHCG) Given Media Sentiment Rating of 0.23

Media stories about LHC Group (NASDAQ:LHCG) have trended somewhat positive on Saturday, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. LHC Group earned a news impact score of 0.23 on Accern’s scale. Accern also gave news coverage about the health services provider an impact score of 46.159332215312 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the media stories that may have impacted Accern Sentiment’s scoring:

How to Become a New Pot Stock Millionaire

Shares of LHCG opened at $75.64 on Friday. The stock has a market capitalization of $1,358.77, a P/E ratio of 31.35, a P/E/G ratio of 1.20 and a beta of 0.70. LHC Group has a 12-month low of $52.56 and a 12-month high of $76.14. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.97 and a current ratio of 1.97.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Wednesday, February 28th. The health services provider reported $0.62 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.62. The firm had revenue of $292.40 million for the quarter, compared to analyst estimates of $280.82 million. LHC Group had a net margin of 4.67% and a return on equity of 9.18%. LHC Group’s revenue was up 24.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.58 EPS. analysts expect that LHC Group will post 3.5 earnings per share for the current year.

LHCG has been the topic of several recent research reports. BidaskClub cut shares of LHC Group from a “sell” rating to a “strong sell” rating in a research report on Wednesday, March 7th. Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “strong-buy” rating and set a $70.00 price target on the stock in a research report on Tuesday, March 6th. Stephens set a $74.00 price target on shares of LHC Group and gave the company a “buy” rating in a research report on Friday, March 2nd. Craig Hallum boosted their price target on shares of LHC Group from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, April 4th. Finally, Jefferies Group reissued a “buy” rating and set a $84.00 price target on shares of LHC Group in a research report on Wednesday, April 4th. Two investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $76.80.

In related news, COO Donald Dwayne Stelly sold 14,216 shares of the business’s stock in a transaction dated Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total value of $909,824.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 14.80% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION WARNING: “LHC Group (LHCG) Given Media Sentiment Rating of 0.23” was reported by Macon Daily and is the sole property of of Macon Daily. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://macondaily.com/2018/04/21/lhc-group-lhcg-given-media-sentiment-rating-of-0-23.html.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply